AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Treatment Considerations for Hematological Malignancies and COVID-19
This chapter discusses various considerations for treating hematological malignancies during the COVID-19 pandemic, including individualizing treatment recommendations based on the specific epidemiological nature of the area and delaying therapy based on the level of crisis. They also mention the use of corticosteroids and transplant, the role of measurable residual disease (MRD), and the need for more evidence in certain areas.